Terms: = Head and neck cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Clinical Outcome
4 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival.
Bouaoud J; Foy JP; Tortereau A; Michon L; Lavergne V; Gadot N; Boyault S; Valantin J; De Souza G; Zrounba P; Bertolus C; Bendriss-Vermare N; Saintigny P
Oncoimmunology; 2021; 10(1):1944554. PubMed ID: 34239777
[TBL] [Abstract] [Full Text] [Related]
3. An extramedullary plasmacytoma in the kidney of a 14-year-old girl: Case report and review of the literature.
Mei YH; Yu JP; Li G
Medicine (Baltimore); 2017 Feb; 96(6):e6092. PubMed ID: 28178171
[TBL] [Abstract] [Full Text] [Related]
4. [Clinicopathological study of 145 childhood rhabdomyosarcoma cases].
He LJ; Wang L; Sun N; Huang CR; Zhu XD; Lang ZQ
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):225-8. PubMed ID: 15256113
[TBL] [Abstract] [Full Text] [Related]
